News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
207,396 Results
Type
Article (20011)
Company Profile (104)
Press Release (187281)
Multimedia
Podcasts (29)
Webinars (9)
Section
Business (65751)
Career Advice (897)
Deals (9614)
Drug Delivery (73)
Drug Development (19691)
Employer Resources (140)
FDA (3534)
Job Trends (6139)
News (99092)
Policy (7758)
Tag
Academia (1518)
Academic (2)
Accelerated approval (1)
Adcomms (16)
Allergies (19)
Alliances (17846)
ALS (28)
Alzheimer's disease (557)
Antibody-drug conjugate (ADC) (61)
Approvals (3550)
Artificial intelligence (125)
Autoimmune disease (10)
Automation (9)
Bankruptcy (52)
Best Places to Work (5023)
BIOSECURE Act (12)
Biosimilars (56)
Biotechnology (64)
Bladder cancer (26)
Brain cancer (7)
Breast cancer (92)
Cancer (673)
Cardiovascular disease (87)
Career advice (786)
Career pathing (31)
CAR-T (57)
Cell therapy (155)
Cervical cancer (8)
Clinical research (15164)
Collaboration (381)
Compensation (97)
Complete response letters (8)
COVID-19 (1019)
CRISPR (25)
C-suite (136)
Cystic fibrosis (40)
Data (680)
Decentralized trials (1)
Denatured (21)
Depression (18)
Diabetes (84)
Diagnostics (2414)
Digital health (5)
Diversity (7)
Diversity, equity & inclusion (37)
Drug discovery (53)
Drug pricing (58)
Drug shortages (4)
Duchenne muscular dystrophy (39)
Earnings (15715)
Editorial (15)
Employer branding (23)
Employer resources (118)
Events (30758)
Executive appointments (412)
FDA (3904)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (371)
Gene editing (44)
Generative AI (14)
Gene therapy (107)
GLP-1 (312)
Government (1404)
Grass and pollen (1)
Guidances (22)
Healthcare (5259)
Huntington's disease (13)
IgA nephropathy (9)
Immunology and inflammation (30)
Indications (7)
Infectious disease (1078)
Inflammatory bowel disease (57)
Inflation Reduction Act (7)
Influenza (16)
Intellectual property (33)
Interviews (128)
IPO (3905)
IRA (17)
Job creations (1329)
Job search strategy (676)
Kidney cancer (1)
Labor market (35)
Layoffs (165)
Leadership (12)
Legal (1522)
Liver cancer (23)
Lung cancer (98)
Lymphoma (58)
Machine learning (1)
Management (42)
Manufacturing (127)
MASH (15)
Medical device (2960)
Medtech (2964)
Mergers & acquisitions (5959)
Metabolic disorders (232)
Multiple sclerosis (39)
NASH (9)
Neurodegenerative disease (27)
Neuropsychiatric disorders (5)
Neuroscience (753)
NextGen: Class of 2025 (2206)
Non-profit (1726)
Now hiring (38)
Obesity (138)
Opinion (99)
Ovarian cancer (23)
Pain (32)
Pancreatic cancer (13)
Parkinson's disease (46)
Partnered (13)
Patents (58)
Patient recruitment (27)
Peanut (13)
People (27507)
Pharmaceutical (25)
Pharmacy benefit managers (18)
Phase I (4349)
Phase II (6165)
Phase III (6144)
Pipeline (348)
Policy (57)
Postmarket research (647)
Preclinical (2471)
Press Release (61)
Prostate cancer (29)
Psychedelics (18)
Radiopharmaceuticals (69)
Rare diseases (124)
Real estate (2558)
Recruiting (54)
Regulatory (5449)
Reports (35)
Research institute (1279)
Resumes & cover letters (138)
Rett syndrome (1)
RNA editing (2)
RSV (26)
Schizophrenia (24)
Series A (76)
Series B (44)
Service/supplier (8)
Sickle cell disease (24)
Special edition (9)
Spinal muscular atrophy (53)
Sponsored (14)
Startups (2017)
State (1)
Stomach cancer (6)
Supply chain (24)
Tariffs (9)
The Weekly (8)
Vaccines (218)
Venture capitalists (29)
Weight loss (94)
Women's health (13)
Worklife (16)
Date
Today (85)
Last 7 days (301)
Last 30 days (937)
Last 365 days (10803)
2025 (3577)
2024 (11929)
2023 (13445)
2022 (16157)
2021 (18418)
2020 (16978)
2019 (15720)
2018 (11397)
2017 (10801)
2016 (10638)
2015 (11286)
2014 (8383)
2013 (7218)
2012 (7590)
2011 (7808)
2010 (7310)
Location
Africa (338)
Alabama (21)
Alaska (4)
Arizona (70)
Arkansas (5)
Asia (11590)
Australia (2124)
California (1858)
Canada (648)
China (150)
Colorado (98)
Connecticut (65)
Delaware (81)
Europe (30232)
Florida (277)
Georgia (63)
Hawaii (1)
Idaho (11)
Illinois (141)
India (19)
Indiana (149)
Iowa (6)
Japan (70)
Kansas (29)
Kentucky (7)
Louisiana (4)
Maine (6)
Maryland (211)
Massachusetts (1529)
Michigan (94)
Minnesota (138)
Mississippi (1)
Missouri (33)
Montana (4)
Nebraska (9)
Nevada (11)
New Hampshire (14)
New Jersey (596)
New Mexico (17)
New York (677)
North Carolina (344)
North Dakota (8)
Northern California (876)
Ohio (69)
Oklahoma (6)
Oregon (17)
Pennsylvania (317)
Puerto Rico (3)
Rhode Island (14)
South America (497)
South Carolina (5)
Southern California (600)
Tennessee (36)
Texas (231)
United States (7321)
Utah (45)
Virginia (66)
Washington D.C. (24)
Washington State (150)
Wisconsin (35)
207,396 Results for "cv sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Lilly Unfazed as CVS Picks Novo’s Side in Obesity Market Battle
Eli Lilly CEO David Ricks is confident that weight loss med Zepbound is gaining market share at the expense of Wegovy, even as its rival strikes deals with CVS and Hims & Hers pharmacies.
May 1, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025
March 20, 2025
·
3 min read
Press Releases
SK Life Science, Inc. to Showcase Important XCOPRI® (cenobamate tablets) CV Data on Responsive Neurostimulation Epileptiform Events at the 77th American Academy of Neurology (AAN) Annual Meeting
April 4, 2025
·
12 min read
Press Releases
CVS Health to hold first quarter 2025 earnings conference call
April 3, 2025
·
1 min read
Press Releases
CVS Health Announces Chief Financial Officer Transition Plan; Appoints Chief Medical Officer
April 8, 2025
·
5 min read
Press Releases
Novo Nordisk announces that CVS Caremark®, the country’s largest PBM, has decided Wegovy® will be the preferred GLP-1 medicine covered for obesity on its template formularies
May 1, 2025
·
9 min read
Press Releases
Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People with HIV
March 12, 2025
·
5 min read
Press Releases
SK Life Science, Inc. Presents XCOPRI® (cenobamate tablets) CV Data at the AES 2024 Annual Meeting Showing a Deeper Understanding of Cenobamate’s Dual Mechanism of Action
December 9, 2024
·
11 min read
Press Releases
CVS Health Announces Board Appointments
November 18, 2024
·
7 min read
Press Releases
CVS Health to hold fourth quarter and full year 2024 earnings conference call
January 13, 2025
·
1 min read
1 of 20,740
Next
